To the best our knowledge, the current study demonstrated for the first time that decreased SPARC expression could significantly inhibit the migration and invasion of ESCC cells in vitro via suppression of epithelial-mesenchymal transition (EMT) through a novel signal transduction pathway involving SPARC, FAK, and ERK. This evidence concerns the gene PTK2 and esophageal squamous cell carcinoma.